Autologous lymphocytes inhibit hemopoiesis in long-term culture in patients with myelodysplastic syndrome

By Baumann I.   Scheid C.   Koref M.S.   Swindell R.   Stern P.   Testa N.G.  

Experimental Hematology, Vol. 30, Iss. 12, 2002-12 ,pp. : 1405-1411

Elsevier

Access to resources Recommend Favorite

Altered Self-reactive Antibody Repertoires are a General Feature of Patients with Myelodysplastic Syndrome

By Stahl D.   Egerer G.   Goldschmidt H.   Sibrowski W.   Kazatchkine M.D.   Kaveri S.V.  

Journal of Autoimmunity, Vol. 16, Iss. 1, 2001-02 ,pp. : 77-86

Academic Press

Access to resources Recommend Favorite

Clinical experience with decitabine in North American patients with myelodysplastic syndrome

By Yee Karen   Jabbour Elias   Kantarjian Hagop   Giles Francis  

Annals of Hematology, Vol. 84, Iss. 1, 2005-12 ,pp. : 18-24

Springer Publishing Company

Access to resources Recommend Favorite

Is it time for 5-azacytidine combinations in high-risk myelodysplastic syndrome patients?

By Park Sophie  

Expert Review of Hematology, Vol. 6, Iss. 1, 2013-02 ,pp. : 39-42

Informa Healthcare

Access to resources Recommend Favorite

Cytogenetic features in myelodysplastic syndromes

By Haase Detlef  

Annals of Hematology, Vol. 87, Iss. 7, 2008-07 ,pp. : 515-526

Springer Publishing Company

Access to resources Recommend Favorite